NG Industries Ltd.
Snapshot View

49.50 -0.60 ▼-1.2%

23 July 2021, 04:00:00 P.M.
Volume: 373

Overview View Details

Sector Healthcare Compare with Sector peers
Industry Hospital & Healthcare Services Compare with Industry peers
Website http://www.ngind.com
Financial Indicators
Market Cap 16.87 Cr.
Earnings per share (EPS) 1.83 Trailing Twelve Months Ending 2021-03
Price-Earning Ratio (PE) 27.57 Trailing Twelve Months Ending 2021-03
Industry PE 223.80 Trailing Twelve Months Ending 2021-03
Book Value / Share 44.79 Trailing Twelve Months Ending 2021-03
Price to Book Value 1.12 Calculated using Price: 50.35
Dividend Yield 0.00 Period Ending 2020-03
No. of Shares Subscribed 0.34 Cr. 3,350,500 Shares
FaceValue 10
Company Profile

N G Industries was incorporated on November 17, 1994 as a public limited company in the state of West Bengal under the Companies Act, 1956 with the main object of rendering diagnostic services. The company obtained the certificate of commencement of business on December 19, 1994.

It operates through two medical branches -- N G Medicare & Calcutta Hope Infertility Clinic, N G Nursing Home and N G Pharmacy. The company has set up a project for multi-speciality diagnostic clinic and day-care centre along with an infertility clinic at Rashbehari Avenue, Calcutta.

The registered office of the company is located at 17, 3rd Floor, Chittaranjan Avenue., Kolkata,West Bengal 700072.

Business area of the company

The company’s principal activity is to provide healthcare and medical services. The company facilitates through the treatments and services like, imaging, cardiology, endoscopy, neurology, pathology, orthopaedics, infertility, surgery, operation theatres, indoor ward and surgery.

Delivery View Details

Delivered Qty
Traded Qty

Performance View Details

1 Day
-1.20%
1 Week
-0.10%
1 Month
-2.94%
3 Month
+4.87%
6 Month
+18.85%
1 Year
+5.77%
2 Year
-13.91%
5 Year
-41.76%
9 years 2012-03 2013-03 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03
Return on Equity (%) 20.45 15.05 10.66 9.97 10.63 9.81 7.18 9.86 14.44
Return on Capital Employed (%) 24.85 17.76 13.62 12.93 15.93 14.33 11.81 14.94 17.80
Return on Assets (%) 17.48 11.37 8.03 8.32 9.10 8.17 6.35 9.59 12.71

Balance Sheet View Details

Particulars 9 years 2012-03 Rs. Cr. 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr.
Shh. Funds 13 14 14 14 14 14 12 11 9
Non Curr. Liab. 0 0 0 0 0 0 -2 -2 -2
Curr. Liab. 3 6 3 3 3 3 2 2 5
Minority Int.
Equity & Liab. 16 20 18 17 17 18 12 11 12
Non Curr. Assets 13 17 15 15 15 15 10 9 9
Curr. Assets 3 3 3 2 2 3 2 3 2
Misc. Exp. not W/O
Total Assets 16 20 18 17 17 18 12 11 12

Profit Loss View Details

Particulars 9 years 2012-03 Rs. Cr. 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr.
Net Sales 13 14 14 15 17 17 17 18 19
Other Income 1 1 1 1 0 0 0 0 0
Total Income 15 15 14 15 17 17 18 18 19
Total Expenditure -10 -11 -11 -12 -14 -15 -15 -15 -16
PBIDT 4 4 3 3 3 3 2 2 3
Interest 0 0 0 0 0 0 0 0 0
Depreciation -1 -1 -1 -1 -1 -1 -1 -1 -1
Taxation -1 -1 -1 -1 -1 -1 -1 -1 -1
Exceptional Items
PAT 3 2 2 1 2 1 1 1 1

Cash Flow View Details

Particulars 9 years 2012-03 Rs. Cr. 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr.
Cash Fr. Operatn. 2 2 2 2 2 2 2 4 3
Cash Fr. Inv. 0 -4 2 -1 -1 -1 -2 -1 -3
Cash Fr. Finan. 0 2 -4 -2 -1 -1 -2 -2 0
Net Change 3 0 0 -1 0 0 -1 1 0
Cash & Cash Eqvt 2 2 2 1 1 1 0 1 1

Shareholding Pattern View Details

9 Qtrs 2019-06 (%) 2019-09 (%) 2019-12 (%) 2020-03 (%) 2020-06 (%) 2020-09 (%) 2020-12 (%) 2021-03 (%) 2021-06 (%)
Promoter 74.50 74.50 74.50 74.50 74.50 74.50 74.50 74.50 74.50
Public 25.50 25.50 25.50 25.50 25.50 25.50 25.50 25.50 25.50
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details

Wed, 21 Jul 2021
Board Meeting Intimation for Consideration And Approval Of Un-Audited Financial Results Of The Company For The First Quarter Ended 30Th June 2021.
N.G.INDUSTRIES LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2021 inter alia to consider and approve Un-audited Financial Results of the Company for the first quarter ended 30th June 2021.
Tue, 13 Jul 2021
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
Compliance Certificate under Reg 74(5) of SEBI (DP) Regulations 2015
Tue, 13 Jul 2021
Statement Of Investor Complaints For The Quarter Ended June 2021
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter
0000
Name of the Signatory :- DIPAK KUMAR SHAW
Designation :- Company Secretary and Compliance Officer

Technical Scans View Details

Fri, 23 Jul 2021
Both SRS And ARS Above Zero Both SRS And ARS Above Zero
ATR Decreasing for 3 Days ATR Decreasing for 3 Days
Thu, 22 Jul 2021
Stock Underperforming Sectoral Index in both 1 Week and 3 Month Stock Underperforming Sectoral Index in both 1 Week and 3 Month
Both SRS And ARS Above Zero Both SRS And ARS Above Zero
MACD Moving Below Zero MACD Moving Below Zero

Related Stocks View Details

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 166,513.85 694.00 +1.0%
Divi's Laboratories Ltd. 128,088.59 4,825.00 -0.4%
Dr. Reddy's Laboratories Ltd. 90,175.51 5,420.50 +0.7%
Cipla Ltd. 76,510.04 948.50 -0.1%
Cadila Healthcare Ltd. 62,965.29 615.05 -0.9%
Aurobindo Pharma Ltd. 56,484.48 964.00 -0.8%
Apollo Hospitals Enterprise Ltd. 56,291.69 3,915.00 -1.8%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2021-03 57.34 694.00 +1.0%
Divi's Laboratories Ltd. Consolidated 2021-03 64.55 4,825.00 -0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 46.21 5,420.50 +0.7%
Cipla Ltd. Consolidated 2021-03 31.81 948.50 -0.1%
Cadila Healthcare Ltd. Consolidated 2021-03 29.51 615.05 -0.9%
Aurobindo Pharma Ltd. Consolidated 2021-03 10.59 964.00 -0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2021-03 374.38 3,915.00 -1.8%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2021-03 3.58 694.00 +1.0%
Divi's Laboratories Ltd. Consolidated 2021-03 13.78 4,825.00 -0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 5.15 5,420.50 +0.7%
Cipla Ltd. Consolidated 2021-03 4.17 948.50 -0.1%
Cadila Healthcare Ltd. Consolidated 2021-03 4.85 615.05 -0.9%
Aurobindo Pharma Ltd. Consolidated 2021-03 2.58 964.00 -0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2021-03 12.25 3,915.00 -1.8%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2020-03 0.18 694.00 +1.0%
Divi's Laboratories Ltd. Consolidated 2020-03 0.00 4,825.00 -0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 0.17 5,420.50 +0.7%
Cipla Ltd. Consolidated 2020-03 0.18 948.50 -0.1%
Cadila Healthcare Ltd. Consolidated 2021-03 0.35 615.05 -0.9%
Aurobindo Pharma Ltd. Consolidated 2020-03 0.33 964.00 -0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2020-03 1.08 3,915.00 -1.8%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2020-03 9.66 694.00 +1.0%
Divi's Laboratories Ltd. Consolidated 2020-03 19.30 4,825.00 -0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 11.53 5,420.50 +0.7%
Cipla Ltd. Consolidated 2020-03 10.09 948.50 -0.1%
Cadila Healthcare Ltd. Consolidated 2021-03 18.30 615.05 -0.9%
Aurobindo Pharma Ltd. Consolidated 2020-03 18.53 964.00 -0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2020-03 13.08 3,915.00 -1.8%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2020-03 10.07 694.00 +1.0%
Divi's Laboratories Ltd. Consolidated 2020-03 25.36 4,825.00 -0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 15.24 5,420.50 +0.7%
Cipla Ltd. Consolidated 2020-03 12.53 948.50 -0.1%
Cadila Healthcare Ltd. Consolidated 2021-03 13.65 615.05 -0.9%
Aurobindo Pharma Ltd. Consolidated 2020-03 18.80 964.00 -0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2020-03 17.13 3,915.00 -1.8%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2020-03 32,837.50 694.00 +1.0%
Divi's Laboratories Ltd. Consolidated 2020-03 5,394.42 4,825.00 -0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 19,047.50 5,420.50 +0.7%
Cipla Ltd. Consolidated 2020-03 17,131.99 948.50 -0.1%
Cadila Healthcare Ltd. Consolidated 2021-03 15,102.20 615.05 -0.9%
Aurobindo Pharma Ltd. Consolidated 2020-03 23,098.51 964.00 -0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2020-03 11,246.80 3,915.00 -1.8%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2020-03 4,186.79 694.00 +1.0%
Divi's Laboratories Ltd. Consolidated 2020-03 1,376.54 4,825.00 -0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 1,903.60 5,420.50 +0.7%
Cipla Ltd. Consolidated 2020-03 1,546.98 948.50 -0.1%
Cadila Healthcare Ltd. Consolidated 2021-03 2,137.60 615.05 -0.9%
Aurobindo Pharma Ltd. Consolidated 2020-03 2,844.69 964.00 -0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2020-03 434.90 3,915.00 -1.8%